# In Vitro Oocyte Maturation With Autologous Exosomes in Women

> **NCT07249411** · NA · COMPLETED · sponsor: **Biotech Fertility C.A.** · enrollment: 32 (actual)

## Conditions studied

- Diminished Ovarian Reserve

## Interventions

- **OTHER:** MI oocytes were cultured in conventional IVM medium supplemented with 10 µg of autologous exosomes obtained using the ExoSMarT® exosome filtration system

## Key facts

- **NCT ID:** NCT07249411
- **Lead sponsor:** Biotech Fertility C.A.
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-01-02
- **Primary completion:** 2025-01-31
- **Final completion:** 2025-01-31
- **Target enrollment:** 32 (ACTUAL)
- **Last updated:** 2025-11-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07249411

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07249411, "In Vitro Oocyte Maturation With Autologous Exosomes in Women". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT07249411. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*